Organometallics
Article
reagents were obtained from commercial sources and used as received.
1,3,5-Trimethoxybenzene was sublimed prior to use. K2PtCl4 was
purchased from Strem Chemicals and was used without further
purification. PtCl2(SMe2)2, Pt2Me4(SMe2)2, and Pt2(CD3)4(SMe2)2
were prepared using previously reported procedures.24 Dimethylzinc
(1.2 M solution in toluene) was purchased from Aldrich and titrated
with LiCl and I2 prior to use.25
(acetonitrile-d3, 300 MHz): δ 8.56 (s, JPt−H = 36.9 Hz, CHN, 1H),
7.76−7.23 (m, overlapping peaks, aryl H), 4.58 (m, CH2, AB pattern,
2H), 1.62 (dd, JPt−H = 59.4 Hz, JF−H = 12 Hz, JP−H = 5 Hz, Pt−CH3,
3H), 0.74 (dd, JPt−H = 61.0 Hz, JF−H = 12 Hz, JP−H = 5 Hz, Pt−CH3,
3H). 19F NMR (acetonitrile-d3, 282 MHz): δ −126.1 (m, aryl F, 1F),
−139.6 (m, aryl F, 1F), −148.1 (m, aryl F, 1F), −164.1 (m, aryl F, 1F),
−273.5 (s, JPt−H = 31.0 Hz, Pt−F, 1F). 31P{1H} NMR (acetonitrile-d3,
121 MHz): δ −0.57 (d, JPt−H = 1614 Hz, JP−F = 52 Hz, Pt−PPh3).
HRMS (ESI positive ion mode): m/z calcd for C34H27F5NP79Br194Pt:
848.0611, found 848.0608.
Preparation of Polyfluoroarenes. All substrates were prepared
according to literature procedures. Analytical data match previously
reported data.11 See the Supporting Information for details.
General Procedure for Preparation of PtIV−F·SMe2 Com-
plexes. In a 20 mL vial in the glovebox, the polyfluoroarene substrate
(0.034 mmol, 1.0 equiv) and Pt2Me4(SMe2)2 (0.017 mmol, 0.5 equiv)
were dissolved in dried, degassed CD3CN (1.0 mL). The resulting
solution was transferred to a screw-cap NMR tube containing a
septum, which was sealed and removed from the glovebox. The
[PtMe2F(PPh3)(C6F2CHNCH2C6H5)] (5). Based on in situ NMR
spectroscopic characterization, 70% conversion based on integration of
1
the 19F NMR spectrum. H NMR (acetonitrile-d3, 300 MHz): δ 8.23
(s, JPt−H = 55.2 Hz, CHN, 1H), 7.66−6.28 (m, overlapping signals,
aryl H), 4.95−4.30 (m, overlapping signals, CH2, 2H), 1.22 (td, JPt−H
66.0 Hz, JP−H = 8 Hz, JF−H = 2 Hz, Pt−CH3, 3H), 0.62 (td, JPt−H
=
=
1
reaction was monitored by H and 19F NMR spectroscopy. Analytical
61.8 Hz, JF−H = 8 Hz, JP−H = 2 Hz, Pt−CH3, 3H). 19F NMR
(acetonitrile-d3, 282 MHz): δ −101.8 (m, aryl F, 1F), −110.5 (m, aryl
F, 1F), −281.3 (m, Pt−F, 1F). 31P{1H} NMR (acetonitrile-d3, 121
MHz): δ −1.72 (d, JPt−P = 1102 Hz, JP−F = 64 Hz, Pt-PPh3). HRMS
(ESI positive ion mode): m/z calcd for C34H31F3NP194Pt 736.1794,
found 736.1782.
data for all Pt complexes are included in the Supporting Information.
Select Pt complexes are included below.
[PtMe2F(SMe2)C6F4CHNCH2C6H4Br)] (1). Based on in situ NMR
spectroscopic characterization, 90% conversion based on integration of
1
the 19F NMR spectrum. H NMR (acetonitrile-d3, 300 MHz): δ 8.98
(s, JPt−H = 48.0 Hz, CHN, 1H), 7.67−7.45 (m, aryl H, 4H), 5.02
[PtMe2Br(PPh3)(C6FCHNCH2C6H5)] (6). Colorless crystals were
obtained from a saturated solution of acetonitrile; 53% yield. 1H NMR
(dichloromethane-d2, 300 MHz): δ 8.11 (s, JPt−H = 49.8 Hz, CHN,
1H), 7.55−7.49 (t, J = 8.7 Hz, 1H), 7.40−7.28 (m, signals overlapping
with PPh3, aryl H), 7.04 (dd, J = 6.6 Hz, J = 4 Hz, 2H), 6.88 (d, AB
pattern, J = 8 Hz), 6.65 (t, J = 9.0 Hz, 1H), 6.45 (d, JPt−H = 43.8 Hz,
1H), 5.03 (d, AB pattern, J = 18.3 Hz). 1.49 (d, Pt−CH3, JH−P = 8 Hz,
JPt−H = 69.3 Hz, 3H), 0.98 (d, Pt−CH3, JH−P = 8 Hz, JPt−H = 58.2 Hz,
(m, 2H), 1.96 (s, JPt−H = 12.0 Hz, S(CH3)2, 6H), 1.50 (dd, JPt−H
=
63.0 Hz, JF−H = 9 Hz, JF−H = 6 Hz, Pt−CH3, 3H), 0.80 (d, JPt−H = 66.0
Hz, JF−H = 6 Hz, Pt−CH3, 3H). 19F NMR (acetonitrile-d3, 282 MHz):
δ −128.2 (m, aryl F, 1F), −139.4 (m, aryl F, 1F), −148.0 (m, aryl F,
1F), −162.8 (m, aryl F, 1F), −253.5 (m, JPt−H = 175 Hz, Pt−F, 1F).
[PtMe2F(SMe2)(C6F2CHNCH2C6H5)] (2). Based on in situ NMR
spectroscopic characterization, 85% conversion based on integration of
1
the 19F NMR spectrum. H NMR (acetonitrile-d3, 300 MHz): δ 8.78
3H). 19F NMR (dichloromethane-d2, 282 MHz): δ −114.0 (m, JPt−F
=
(s, JPt−H = 47.5 Hz, CHN, 1H), 7.70−6.60 (m, overlapping peaks,
42 Hz, aryl F). 31P{1H} NMR (dichloromethane-d2, 121 MHz): δ
−7.2 (s, JPt−P = 1006 Hz, Pt−PPh3). 13C{1H} NMR (dichloro-
aryl H), 5.05 (m, CH2, 2H), 1.90 (s, JPt−H = 12.1 Hz, S(CH3)2, 6H),
1.11 (d, JPt−H = 65.6 Hz, JF−H = 7 Hz, Pt−CH3, 3H), 0.72 (d, JPt−H
=
methane-d2, 150 MHz): 166.1 (s, JPt−C = 54.8 Hz), 161.1 (d, JF−C =
68.3 Hz, JF−H = 7 Hz, Pt−CH3, 3H). 19F NMR (acetonitrile-d3, 282
MHz): δ −101.8 (m, aryl F, 1F), −110.5 (m, aryl F, 1F), −260.9 (br s,
Pt−F, 1F).
965.0 Hz, JPt−C = 51.3 Hz), 151.5 (d, JF−C = 21.4 Hz, JPt−C = 932.7
Hz), 136.3 (s), 134.4 (s), 131.3 (d, JP−C = 33.8 Hz), 130.9 (d, JF−C
=
146.0 Hz, JPt−C = 11.4 Hz), 130.6 (s), 130.4 (d, JF−C = 9.0 Hz), 130.2
(d, JF−C = 29.9 Hz), 129.2 (s), 128.5 (s), 128.4 (d, JP−C = 18.5 Hz),
124.6 (d, JF−C = 16.9 Hz, JPt−C = 41.0 Hz), 60.5 (s, JPt−C = 12.6 Hz),
10.56 (s, JPt−C = 491.6 Hz), −4.43 (d, JP−C = 7.0 Hz, JPt−C = 618.0 Hz).
HRMS (ESI positive ion mode): m/z calcd for C34H3279BrFNP194Pt
779.1084, found 779.1086. Anal. Calcd for C34H32BrFNPPt: C, 54.69;
H, 4.20; N, 1.82. Found: C, 55.10; H, 4.34; N, 1.60.
[PtMe2Br(SMe2)(C6FCHNCH2C6H5)] (3). Based on in situ NMR
spectroscopic characterization, 95% conversion based on integration of
1
the 19F NMR spectrum. H NMR (acetonitrile-d3, 300 MHz): δ 8.73
(s, JPt−H = 45.0 Hz, CHN, 1H), 7.80−6.52 (m, overlapping peaks,
aryl H), 4.84 (m, CH2, 2H), 1.87 (s, JPt−H = 12.0 Hz, Pt−S(CH3)2,
6H), 1.07 (s, JPt−H = 68.4 Hz, Pt−CH3, 3H), 0.71 (s, JPt−H = 69.6 Hz,
Pt−CH3, 3H). 19F NMR (acetonitrile-d3, 282 MHz): δ −114.6 (d, J =
10 Hz, aryl F, 1F).
[Pt(CD3)2F(SMe2)(C6F2CHNCH2C6H5)] (13). In a 20 mL vial in the
glovebox, N-(2,4,6-trifluorobenzylidene)benzylamine (0.080 g, 0.032
mmol, 1.0 equiv) and Pt2(CD3)4(SMe2)2 (0.94 g, 0.016 mmol, 0.5
equiv) were dissolved in CD3CN (1.0 mL). The resulting solution was
transferred into an NMR tube, which was then fitted with a screw cap
containing a septum. The reaction was monitored by 1H and 19F NMR
[PtMe2F(PPh3)(C6F4CHNCH2C6H5)] (10). Based on in situ NMR
spectroscopic characterization, 42% conversion based on integration of
1
the 19F NMR spectrum. H NMR (acetonitrile-d3, 300 MHz): δ 8.71
(s, JPt−H = 39.0 Hz, CHN, 1H), 7.50 −7.31 (m, overlapping peaks,
aryl H), 4.66 (dd, JH−H = 10.8 Hz, CH2, AB pattern, 2H), 1.72 (dd,
JPt−H = 58.5 Hz, JF−H = 12 Hz, JP−H = 5 Hz, Pt−CH3, 3H), 0.72 (dd,
JPt−H = 62.0 Hz, JF−H = 12 Hz, JP−H = 5 Hz, Pt−CH3, 3H). 19F NMR
(acetonitrile-d3, 282 MHz): δ −124.9 (m, aryl F, 1F), −141.1 (m, aryl
F, 1F), −150.3 (m, aryl F, 1F), −165.6 (m, aryl F, 1F), −275.6 (s,
JPt−H = 32.0 Hz, Pt−F, 1F). 31P{1H} NMR (acetonitrile-d3, 121 MHz):
δ −2.0 (d, JPt−H = 999 Hz). HRMS (ESI positive ion mode): m/z calcd
for C34H29F5NP194Pt 772.1606, found 772.1612.
spectroscopy: >95% conversion based on in situ NMR spectroscopic
1
characterization. H NMR (acetonitrile-d3, 300 MHz): δ 8.78 (s, JPt−H
=
47.1 Hz, CHN, 1H), 7.80−6.60 (m, overlapping peaks, aryl H),
5.05 (m, CH2, 2H), 1.89 (s, JPt−H = 12.0 Hz, S(CH3)2, 6H). As
expected, there were no resonances for Pt−CD3 signals. 19F NMR
(acetonitrile-d3, 282 MHz): δ −102.0 (m, aryl F, 1F), −110.7 (m, aryl
F, 1F), −261.8 (br s, Pt−F, 1F).
General Procedure for Preparation of Me3PtIV·SMe2 Com-
plexes. In a 20 mL vial in the glovebox, substrate (0.085 g, 0.034
mmol, 1.0 equiv) and Pt2Me4(SMe2)2 (0.098 g, 0.017 mmol, 0.5
equiv) were dissolved in CD3CN (1.0 mL). Me2Zn (20 μL, 0.040
mmol, 2.0 M solution in toluene) was subsequently added by syringe.
The resulting solution was transferred to an NMR tube, which was
then fitted with a screw cap containing a septum. The NMR tube was
General Procedure for Preparation of Me2PtIV−F·PPh3
Complexes. In a 20 mL vial in the glovebox, the substrate (0.085
g, 0.034 mmol, 1.0 equiv) and Pt2Me4(SMe2)2 (0.098 g, 0.017 mmol,
0.5 equiv) were dissolved in CD3CN (1.0 mL). The vial was left to
stand for 24 h, after which triphenylphosphine (0.090 g, 0.034 mmol,
1.0 equiv) was added into the vial. The vial was stirred until complete
dissolution of the triphenylphosphine; the sample was then transferred
to a screw-cap NMR tube and removed from the glovebox. The
1
removed from the glovebox. The reaction was monitored by H and
19F NMR spectroscopy.
[PtMe3(SMe2)(C6F2CHNCH2C6H5)] (8). Based on in situ NMR
spectroscopic characterization, >95% conversion from PtIV−F·SMe2
1
1
1
reaction was monitored by H, 19F, and 31P{1H} NMR spectroscopy
complex 2 based on integration of the H NMR spectrum. H NMR
(acetonitrile-d3, 300 MHz): δ 8.86 (s, JPt−H = 40.0 Hz, 1H, CHN),
7.37−7.13 (m, overlapping peaks, aryl H), 4.99 (m, CH2, 2H), 1.78 (s,
JPt−H= 13.0 Hz, S(CH3)2, 6H), 0.75 (s, JPt−H = 69.0 Hz, Pt−CH3, 3H),
over 24 h.
[PtMe2F(PPh3)(C6F4CHNCH2C6H4Br)] (4). Colorless crystals were
obtained from a saturated solution of acetonitrile; 40% yield. 1H NMR
1405
dx.doi.org/10.1021/om2007562 | Organometallics 2012, 31, 1397−1407